NasdaqCM - Delayed Quote • USD
Aptevo Therapeutics Inc. (APVO)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 7:47 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-11,730.0000
-11,730.0000
-21,022.0000
-21,679.0000
-29,318.0000
Investing Cash Flow
--
--
-29.0000
-713.0000
28,032.0000
Financing Cash Flow
5,998.0000
5,998.0000
-2,616.0000
26,161.0000
23,874.0000
End Cash Position
16,904.0000
16,904.0000
22,636.0000
46,303.0000
42,534.0000
Capital Expenditure
-147.0000
--
-29.0000
-713.0000
-88.0000
Issuance of Capital Stock
6,428.0000
6,428.0000
6,934.0000
10,233.0000
--
Issuance of Debt
--
--
--
--
24,731.0000
Repayment of Debt
-3,467.0000
-3,467.0000
-12,267.0000
-10,550.0000
-22,104.0000
Free Cash Flow
-11,730.0000
-11,730.0000
-21,051.0000
-22,392.0000
-29,406.0000
12/31/2020 - 7/20/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALLR Allarity Therapeutics, Inc.
1.4300
+4.38%
GLTO Galecto, Inc.
0.6689
-0.31%
EFTR eFFECTOR Therapeutics, Inc.
1.8100
-2.16%
KA Kineta, Inc.
0.6398
+3.19%
PHIO Phio Pharmaceuticals Corp.
0.7060
+5.22%
RNAZ TransCode Therapeutics, Inc.
0.5250
+19.35%
REVB Revelation Biosciences, Inc.
2.1399
+2.39%
QNRX Quoin Pharmaceuticals, Ltd.
0.6300
-1.95%
WINT Windtree Therapeutics, Inc.
5.07
-1.65%
TCBP TC Biopharm (Holdings) Plc
1.5700
+6.80%